| Literature DB >> 33145054 |
Kazuhito Funai1, Akikazu Kawase1, Kei Shimizu1, Keigo Sekihara1, Takashi Yamashita1, Norihiko Shiiya1.
Abstract
BACKGROUND: Pulmonary segmentectomy is an important surgical option for complete resection in patients with poor lung function. However, correctly recognizing the intersegmental plane for accurate segmentectomy is sometimes difficult. We therefore developed a novel method that allows the detection of intersegmental planes using an indocyanine green (ICG) fluorescence imaging device, photodynamic eye (PDE) camera, PDE-neo.Entities:
Keywords: Emphysema; fluorescence imaging; indocyanine green (ICG); lung neoplasms; segmentectomy
Year: 2020 PMID: 33145054 PMCID: PMC7578513 DOI: 10.21037/jtd-20-1448
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1PDE-neo consists of a camera unit, a controller, and a remote controller; the camera unit measures 80×182×80 mm (width, depth, height). In the surgical field, it is used in a dedicated sterilized drape. (Extracted from the catalog).
Figure 2A mixture of ICG and autologous blood was introduced into the resected segmental bronchial stump (S2+3) by mixing them with air using a spray set for fibrin glue (BOLHEAL® Spray Set; Akita Sumitomo Bakelite Co., Ltd., Akita, Japan) (Case 2).
Figure 3A volume of 5 mL each of ICG and autologous blood were mixed. The mixture emits fluorescence when observed with PDE.
Figure 4Determination of the intersegmental demarcation line by ICG fluorescence, PDE-neo, is shown. The segment to be resected is displayed in white.
Patient characteristics
| Case | Age | Sex | Diagnosis | Smoking | FEV1.0% | Comorbidity | TNM | Tumor diameter | Solid or not solid | Location of the tumor |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 75 | M | Ad-Sq | 1,200 | 76 | DM, CKD | T1aN0M0 | 22 | Solid | S10 |
| 2 | 36 | M | Ad | 0 | 72 | T1aN0M0 | 8 | Part-solid | S2 | |
| 3 | 73 | M | Ad | 430 | 68 | T1aN0M0 | 17 | Solid | S1+2 | |
| 4 | 70 | M | Ad | 600 | 91 | Laryngeal cancer | T1aN0M0 | 15 | Part-solid | S6 |
| 5 | 68 | M | Ad | 0 | 81 | ICH, ML | T1bN0M0 | 20 | Part-solid | S1+2 |
| 6 | 60 | F | Carcinoid | 0 | 76 | HT, Cushing synd. | T1aN0M0 | 10 | Solid | S6 |
| 7 | 29 | M | Metastasis | 160 | 85 | Parotid adenocarcinoma, Arrhythmia | − | 5 | Solid | S3 |
| 8 | 76 | F | Ad | 0 | 82 | Breast cancer, HT | T1cN0M0 | 9 | Solid | S6 |
| 9 | 60 | M | Ad | 240 | 74 | Gastric cancer, Prostate cancer | T1bN0M0 | 19 | Part-solid | S1+2 |
| 10 | 70 | M | Ad | 0 | 98 | MM | T1aN0M0 | 19 | Part-solid | S9 |
DM, diabetes mellitus; CKD, chronic kidney disease; GGN, ground-glass nodule; ICH, intracerebral hemorrhage; ML, malignant lymphoma; HT, hypertension; MM, malignant melanoma.
Operative results
| Case | Operation time (min) | Blood | Segmentectomy regions | Division of segmental planes | Additional sealing | Duration of drainage (days) | Length of stay (days) | Complications | Clavien-Dindo classification |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 228 | 220 | Left basal | Cautery | Suture, PGA sheets, fibrin glue | 5 | 11 | ||
| 2 | 254 | 20 | Right S2+S3 | Staple and cautery | PGA sheets, fibrin glue | 3 | 10 | Wound infection | Grade I |
| 3 | 203 | 240 | Left upper division | Staple and cautery | PGA sheets, fibrin glue | 3 | 14 | Pneumonia | Grade I |
| 4 | 173 | 20 | Left S6 | Staple and cautery | PGA sheets, fibrin glue | 4 | 8 | ||
| 5 | 188 | Few | Left upper division | Staple and cautery | Suture, PGA sheets, fibrin glue | 3 | 16 | Pneumonia | Grade II |
| 6 | 219 | 120 | Left S6 | Staple and cautery | PGA sheets, fibrin glue | 3 | 8 | ||
| 7 | 161 | 15 | Left lingual | Staple and cautery | Soft coagulation, PGA sheets, fibrin glue | 4 | 8 | ||
| 8 | 203 | 200 | Right S6 | Cautery | Soft coagulation, PGA sheets | 2 | 65 | Wound infection | Grade IIIb |
| 9 | 158 | 10 | Left upper division | Staple and cautery | Soft coagulation, PGA sheets | 4 | 7 | ||
| 10 | 151 | 30 | Left basal | Staple | Suture, Soft coagulation, PGA sheets, fibrin glue | 11 | 15 | Prolonged air leak | Grade IIIa |
Figure 5The 5-year cause-specific survival rate was 100%.
Figure 6The 5-year overall survival rate was 79%. Median survival time was not reached.